TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Biotage AB
Closing information (x1000 EUR)
| Closing information | 2024/12 (consolidated) | 2023/12 (consolidated) | 2022/12 (consolidated) |
| Turnover |
178,993
|
167,808
|
140,722 |
| Financial expenses |
5,833
|
3,695
|
1,258 |
| Earnings before taxes |
28,555
|
27,307
|
31,272 |
| EBITDA |
49,449
|
41,727
|
38,550 |
| Total assets |
444,348
|
444,394
|
210,185 |
| Current assets |
118,226
|
130,407
|
92,647 |
| Current liabilities |
50,320
|
63,176
|
37,202 |
| Equity capital |
358,073
|
329,578
|
147,102 |
| - share capital |
9,838
|
10,094
|
8,357 |
| Employees (average) |
673
|
674
|
517 |
Financial ratios
| Fiscal year | 2024/12 (consolidated) | 2023/12 (consolidated) | 2022/12 (consolidated) |
| Solvency |
80.6%
|
74.2%
|
70.0% |
| Turnover per employee |
266
|
249
|
272 |
| Profit as a percentage of turnover |
16.0%
|
16.3%
|
22.2% |
| Return on assets (ROA) |
7.7%
|
7.0%
|
15.5% |
| Current ratio |
234.9%
|
206.4%
|
249.0% |
| Return on equity (ROE) |
8.0%
|
8.3%
|
21.3% |
| Change turnover |
16,889
|
26,676
|
30,014 |
| Change turnover % |
10%
|
19%
|
27% |
| Chg. No. of employees |
-1
|
157
|
20 |
| Chg. No. of employees % |
0%
|
30%
|
4% |
Total value of public sale
| Fiscal year | 2024/12 (consolidated) | 2023/12 (consolidated) | 2022/12 (consolidated) |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.